tiprankstipranks
Chemcon Speciality Chemicals Ltd (IN:CHEMCON)
:CHEMCON
India Market
Want to see IN:CHEMCON full AI Analyst Report?

Chemcon Speciality Chemicals Ltd (CHEMCON) AI Stock Analysis

1 Followers

Top Page

IN:CHEMCON

Chemcon Speciality Chemicals Ltd

(CHEMCON)

Select Model
Select Model
Select Model
Neutral 70 (OpenAI - Gpt-5.6Sol)
Rating:70Neutral
Price Target:
₹219.00
▲(25.00% Upside)
Action:Downgraded
Date:09/06/26
The score is primarily driven by solid financial stability and improved FY2026 cash generation, tempered by significant margin compression that weakens profitability. Technicals add support with an established uptrend above major moving averages, while valuation is only moderate due to a ~25.8 P/E despite a supportive ~3.25% dividend yield.
Positive Factors
Conservative leverage
Very low leverage gives Chemcon financial flexibility to withstand operating volatility and fund growth without relying heavily on external borrowing. A conservative capital structure also limits interest burden and refinancing exposure, supporting resilience over the next several quarters.
Negative Factors
Sharp margin compression
The substantial decline in gross and net margins signals materially weaker earnings power than in the prior year. If pricing pressure, product mix changes or cost inflation persist, revenue growth may translate into less profit and constrain reinvestment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative leverage
Very low leverage gives Chemcon financial flexibility to withstand operating volatility and fund growth without relying heavily on external borrowing. A conservative capital structure also limits interest burden and refinancing exposure, supporting resilience over the next several quarters.
Read all positive factors

Chemcon Speciality Chemicals Ltd (CHEMCON) vs. iShares MSCI India ETF (INDA)

Chemcon Speciality Chemicals Ltd Business Overview & Revenue Model

Company Description
Founded in 1988 and headquartered in Vadodara, India, Chemcon Speciality Chemicals Limited is a producer and vendor of a diverse range of chemical products. The company primarily focuses on manufacturing pharmaceutical intermediates, silanes, and ...
How the Company Makes Money
Chemcon primarily makes money by manufacturing and selling specialty chemicals to business customers (B2B). Its revenue model is driven by (1) product sales from its specialty chemicals portfolio (including HMDS and other inorganic specialty chemi...

Chemcon Speciality Chemicals Ltd Financial Statement Overview

Summary
Financials are supported by low leverage (debt-to-equity ~0.11) and a strong FY2026 cash flow rebound (FCF ~409.6M; ~0.82x of net income). Offsetting this, profitability weakened materially with sharp gross margin compression (~21.9% vs ~41.9% in FY2025) and lower net margin (~9.8% vs ~11.8%), indicating reduced earnings power versus prior stronger years.
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.53B2.40B2.07B2.67B3.01B2.57B
Gross Profit659.88M524.77M869.50M758.95M1.27B1.17B
EBITDA459.28M456.25M328.58M400.64M840.11M908.34M
Net Income281.74M235.98M244.52M191.93M551.10M627.57M
Balance Sheet
Total Assets0.005.68B5.54B5.45B5.53B4.98B
Cash, Cash Equivalents and Short-Term Investments1.96B1.96B1.51B230.80M604.87M1.12B
Total Debt0.00531.37M246.90M427.39M640.15M360.20M
Total Liabilities-4.83B844.38M532.81M688.34M959.98M808.06M
Stockholders Equity4.83B4.83B5.01B4.76B4.57B4.17B
Cash Flow
Free Cash Flow285.20M409.59M309.45M-308.77M-334.54M241.36M
Operating Cash Flow356.48M501.51M405.17M119.64M127.43M742.22M
Investing Cash Flow11.03M-460.09M-189.15M-245.58M-163.41M-925.48M
Financing Cash Flow-248.62M-8.79M-215.42M-247.73M120.41M298.18M

Chemcon Speciality Chemicals Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price175.20
Price Trends
50DMA
188.64
Positive
100DMA
183.04
Positive
200DMA
178.69
Positive
Market Momentum
MACD
4.18
Negative
RSI
65.73
Neutral
STOCH
70.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMCON, the sentiment is Positive. The current price of 175.2 is below the 20-day moving average (MA) of 195.50, below the 50-day MA of 188.64, and below the 200-day MA of 178.69, indicating a bullish trend. The MACD of 4.18 indicates Negative momentum. The RSI at 65.73 is Neutral, neither overbought nor oversold. The STOCH value of 70.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CHEMCON.

Chemcon Speciality Chemicals Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹134.64B31.160.64%5.09%5.44%
70
Neutral
₹7.30B27.253.12%17.43%10.62%
68
Neutral
₹101.39B44.760.51%5.11%20.64%
59
Neutral
₹214.86B92.4533.79%34.24%
59
Neutral
₹131.93B38.740.29%21.63%60.79%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
₹140.37B80.200.12%51.77%36.94%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
208.00
-11.73
-5.34%
IN:AETHER
Aether Industries Ltd.
1,643.35
902.80
121.91%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,971.65
-47.36
-2.35%
IN:ANURAS
Anupam Rasayan India Ltd.
1,237.25
155.40
14.36%
IN:PRIVISCL
Privi Speciality Chemicals Limited
3,463.60
1,193.53
52.58%
IN:VINATIORGA
Vinati Organics Limited
1,345.25
-371.08
-21.62%

Chemcon Speciality Chemicals Ltd Corporate Events

Chemcon publishes Q1 FY27 unaudited results in newspapers and online
Aug 4, 2026
Chemcon Speciality Chemicals Ltd has published its unaudited financial results for the quarter ended 30 June 2026 in Gujarati daily Loksatta Jansatta and English business daily Business Standard, in line with regulatory disclosure norms. The compa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2026